Get the Stockscreener App
81.24
1.84%
-1.52
U S Physical Therapy Inc stock is traded at $81.24, with a volume of 364.06K.
It is down -1.84% in the last 24 hours and up +16.06% over the past month.
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
See More
Previous Close:
$82.76
Open:
$81.8
24h Volume:
364.06K
Relative Volume:
1.51
Market Cap:
$1.21B
Revenue:
$795.49M
Net Income/Loss:
$62.33M
P/E Ratio:
163.56
EPS:
0.4967
Net Cash Flow:
$67.97M
1W Performance:
+1.49%
1M Performance:
+16.06%
6M Performance:
-6.56%
1Y Performance:
-5.51%
1-Day Range:
$78.63
$81.80
1-Week Range:
$78.39
$83.43
52-Week Range:
$58.19
$93.50
U S Physical Therapy Inc Stock (USPH) Company Profile
Name
U S Physical Therapy Inc
Sector
Industry
Phone
(713) 297-7000
Address
1300 WEST SAM HOUSTON PARKWAY SOUTH, HOUSTON, TX
Compare USPH vs HCA, THC, FMS, EHC, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
USPH
U S Physical Therapy Inc
|
81.24 | 1.22B | 795.49M | 62.33M | 67.97M | 0.4967 |
HCA
Hca Healthcare Inc
|
404.68 | 89.76B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
267.90 | 21.48B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.77 | 12.62B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
123.59 | 12.31B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
180.06 | 11.58B | 13.84B | 1.10B | 1.49B | 10.42 |
U S Physical Therapy Inc Stock (USPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-26 | Resumed | Jefferies | Buy |
| Sep-18-25 | Resumed | JP Morgan | Overweight |
| Dec-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-16-24 | Initiated | JMP Securities | Mkt Outperform |
| Oct-07-24 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-22-23 | Initiated | JP Morgan | Overweight |
| Jun-30-23 | Initiated | BofA Securities | Buy |
| Dec-14-21 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Aug-06-21 | Reiterated | Barrington Research | Outperform |
| May-07-21 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-03-21 | Upgrade | Jefferies | Hold → Buy |
| Feb-26-21 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-08-20 | Reiterated | Barrington Research | Outperform |
| Apr-30-20 | Downgrade | Sidoti | Buy → Neutral |
| Mar-11-20 | Upgrade | Sidoti | Neutral → Buy |
| Feb-28-20 | Reiterated | Barrington Research | Outperform |
| Nov-08-19 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-08-19 | Initiated | William Blair | Outperform |
| Nov-03-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-08-17 | Upgrade | Sidoti | Neutral → Buy |
| Jul-03-17 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-17-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Nov-04-16 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Aug-05-16 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| May-06-16 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-01-16 | Downgrade | Jefferies | Buy → Hold |
| Nov-06-15 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| May-06-15 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-12-13 | Reiterated | Dougherty & Company | Buy |
| Aug-23-13 | Reiterated | Dougherty & Company | Buy |
| Jan-14-13 | Reiterated | Dougherty & Company | Buy |
| Jul-09-10 | Initiated | JMP Securities | Mkt Outperform |
View All
U S Physical Therapy Inc Stock (USPH) Latest News
U.S. Physical Therapy (NYSE:USPH) Trading Down 4.8%Here's Why - MarketBeat
U.S. Physical Therapy Announces New CFO - Baystreet.ca
USPH Looks 20.4% Undervalued on GF Value™ - GuruFocus
U.S. Physical Therapy, Inc. Announces CFO Changes - marketscreener.com
U.S. Physical Therapy Names Nchacha Etta Chief Financial Officer - citybiz
U.S. Physical Therapy names Nchacha Etta as CFO - Investing.com
U.S. Physical Therapy Announces CFO - Yahoo! Finance Canada
Bank of America Corp DE Grows Position in U.S. Physical Therapy, Inc. $USPH - MarketBeat
Kayne Anderson Rudnick (USPH) discloses 846,674-share, 5.6% stake in US Physical Therapy - Stock Titan
(USPH) and the Role of Price-Sensitive Allocations - Stock Traders Daily
U.S. Physical Therapy, Inc. (USPH) Stock Forecasts - finance.yahoo.com
U.S. Physical Therapy Updates Strategic Investor Presentation - TipRanks
Morgan Stanley (USPH) cuts U S Physical Therapy stake to 3.9% of shares - Stock Titan
Q2 2026 US Physical Therapy Inc Earnings Call Transcript - GuruFocus
$81.795 | US Physical Therapy Inc (USPH) Stock Price Today - Binance
US Physical Therapy Reports Strong Q2 2026 Performance - TipRanks
USPH Maintains Outperform by Barrington Research -- Price Target Raised to $98.00 - GuruFocus
Barrington Research Issues Positive Forecast for U.S. Physical Therapy (NYSE:USPH) Stock Price - MarketBeat
US PHYSICAL THERAPY INC : BARRINGTON RESEARCH RAISES TARGET PRICE TO $98 FROM $90 - Bitget
BOOT BARN HOLDINGS INC : STEPHENS RAISES TARGET PRICE TO $207 FROM $196 - Bitget
CYTOKINETICS, INCORPORATED : LEERINK PARTNERS RAISES TARGET PRICE TO $103 FROM $100 - Bitget
SPECTRUM BRANDS HOLDINGS, INC. : MONNESS CRESPI HARDT RAISES TARGET PRICE TO $105 FROM $86 - Bitget
U.S. Physical Therapy, Inc. (NYSE:USPH) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Royal Bank of Canada Has $10.03 Million Stock Holdings in U.S. Physical Therapy, Inc. $USPH - MarketBeat
Rising Sales but Falling EPS and New Dividend Might Change The Case For Investing In U.S. Physical Therapy (USPH) - simplywall.st
U.S. Physical Therapy Q2 Earnings Call Highlights - TradingView
US Physical Therapy Inc (USPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
U.S. Physical Therapy (USPH) Revenue Beat Raises The Question Of Fair Value - Sahm
USPH SWOT Analysis: Financial Resilience and Growth Potential Re - GuruFocus
U.S. Physical Therapy, Inc. (NASDAQ: USPH) grows revenue as profits soften - Stock Titan
U.S. Physical Therapy (USPH): Return Expectations Tempered Despite Solid Execution - Yahoo Finance
U.S. Physical Therapy Inc. (UPH.SG) Q1 FY2026 earnings call transcript - Yahoo Finance
Is US Physical Therapy Inc (USPH) Undervalued After a Mixed Q2 E - GuruFocus
U.S. Physical Therapy (USPH) Stock Profit Rebound Meets Margin And P E Doubts - Sahm
Earnings call transcript: US Physical Therapy misses Q2 2026 profit view as stock falls - Investing.com Nigeria
US Physical Therapy Inc (USPH) (Q2 2026) Earnings Call Highlight - GuruFocus
U.S. Physical Therapy Continues To Heal (NYSE:USPH) - Seeking Alpha
US Physical Therapy Inc (USPH) (Q2 2026) Earnings Call Highlights: Record Visits and Raised ... - Yahoo Finance
BofA Securities Maintains US Physical Therapy(USPH.US) With Buy Rating, Announces Target Price $88 - Moomoo
U.S. Physical Therapy Q2 2026 Earnings Call Transcript - MarketBeat
U.S. Physical Therapy, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
U.S. Physical Therapy, Inc. (NYSE:USPH) to Issue $0.46 Quarterly Dividend - MarketBeat
Press Release: USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance - Moomoo
U.S. Physical Therapy posts revenue growth but EPS misses due to costs, maintaining Hold rating. - pluang.com
U.S. Physical Therapy (USPH) Posted Mixed Q2 Results, Is The Stock Still Undervalued? - Yahoo Finance
U.S. Physical Therapy (USPH) Lags Q2 Earnings Estimates - Yahoo Finance
U.S. Physical Therapy (USPH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
William Blair Maintains US Physical Therapy(USPH.US) With Hold Rating - Moomoo
USPH Looks 28.4% Undervalued on GF Value™ - GuruFocus
US Physical Therapy Inc reports results for the quarter ended June 30Earnings Summary - TradingView
U.S. Physical Therapy: Q2 Earnings Snapshot - marketscreener.com
U S Physical Therapy Inc Stock (USPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.64%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):